Insight

Manel Esteller: Epigenetic Hallmarks in Cancer in Cancer Discovery

Manel Esteller/X

Oct 8, 2024, 15:49

Manel Esteller: Epigenetic Hallmarks in Cancer in Cancer Discovery

Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, shared a post on X:

“Epigenetic Hallmarks in Cancer in Cancer Discovery, AACR Promoter CpG island hypermethylation-associated silencing targets all classical and new dimension hallmarks of cancer by Weinberg MIT, Whitehead Institute and Hanahan, Ludwig Cancer, EPFL.”

Manel Esteller

The Epigenetic Hallmarks of Cancer

Source: Manel Esteller, Mark A. Dawson, Cigall Kadoch, Feyruz V. Rassool, Peter A. Jones, Stephen B. Baylin

Manel Esteller

AACR cancer Cancer Discovery Cigall Kadoch EPFL Feyruz V. Rassool Hanahan Josep Carreras Leukaemia Research Institute Ludwig Cancer Manel Esteller Mark A. Dawson OncoDaily Oncology Peter A. Jones Stephen B. Baylin Weinberg MIT Whitehead Institute

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC